Andrew Parker: key facts
- Kind of voice
- Sector leader
- Role
- PhD, executive drug development consultant, Quotient Sciences
- Quoted on
- Rare diseases
- Tracked press citations
- 2
- Most recently quoted
- 30 Sept 2026
“AI is integrated into pharmaceutical development”
What Andrew Parker has said
“explains how AI is integrated into pharmaceutical development”
PhD, executive drug development consultant, Quotient Sciences · Rare diseases · 30 Sept 2026 · Outsourcing Formulation Activities May Advance Drug Development ↗
Where Andrew Parker has been quoted
- Optimizing Impact for Rare Diseasespharmtech.com · 30 Sept 2026
- Outsourcing Formulation Activities May Advance Drug Developmentpharmtech.com · 30 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.